Skip to search formSkip to main contentSkip to account menu

Subcutaneous Infusions

Known as: Infusion, Subcutaneous, Infusions, Subcutaneous, Subcutaneous Infusion 
The administration of liquid medication or nutrients under the skin, usually over minutes or hours.
National Institutes of Health

Related topics

Related topics

3 relations
Subcutaneous Absorptionnursing therapystandards characteristics

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2010
2010
Dalteparin, a low-molecular-weight heparin, promotes angiogenesis mediated by heparin-binding VEGF-A in vivo
Norrby K, Nordenhem A. Dalteparin, a low‐molecular‐weight heparin, promotes angiogenesis mediated by heparin‐binding VEGF‐A in… 
Highly Cited
2001
Highly Cited
2001
Passive immunization against nicotine prevents nicotine alleviation of nicotine abstinence syndrome
Highly Cited
2000
Highly Cited
2000
Hormonal therapy for short bowel syndrome.
Review
1996
Review
1996
Chronic nausea in advanced cancer patients: a retrospective assessment of a metoclopramide-based antiemetic regimen.
1988
1988
Evidence for a selective antileukemic effect of cytosine arabinoside in chronic granulocytic leukemia.
1985
1985
The effect of long-term near normal glycemic control on mild diabetic retinopathy.
Highly Cited
1984
Highly Cited
1984
Corticotropin-releasing factor differentially regulates proopiomelanocortin messenger ribonucleic acid levels in anterior as compared to intermediate pituitary lobes of rats.
Highly Cited
1982
Highly Cited
1982
Pharmacokinetics of continuous intravenous and subcutaneous infusions of cytosine arabinoside.
The pharmacokinetics of continuous subcutaneous cytosine arabinoside (ara-C) infusions were compared with continuous intravenous… 
1982
1982
High-dose immunoglobulin replacement therapy by slow subcutaneous infusion during pregnancy.
The slow, subcutaneous infusion method of immune human serum globulin replacement was used during pregnancy in a woman with… 
Highly Cited
1977
Highly Cited
1977
EFFECT OF DOSE, TIME, AND ASCORBATE ON IRON EXCRETION AFTER SUBCUTANEOUS DESFERRIOXAMINE
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)